QUALITY PRODUCTS

Tian Xian Liquid

$1,650.00

Specification: 1 carton contain 3 small boxes ( 20 bottles in each box)

 

Ingredients: Cordycepts, Ganoderma extract, Astragalus extract, ginseng extract, yam extract, wolfberry extract, licorice extract, pearl, Ligustrum lucidum extract, diffusa extract.

AVAILABILITY: In Stock
QTY
- +
ADD TO WISH LIST

TXL uses the herbs harvested from Changbai Mountain in Jilin Province, China and it has been verified by medicinal studies. This is a compound Chinese herbal medicine developed based on the Chinese medicinal science. TXL is produced under the most advanced biotechnological processes of extraction, and the production undergoes stringent GMP standards and requirements. It contains no chemical substance and toxicity. It is a supplement to help cancer patients to reduce the risk of cancer recurrence.

 

 

Twenty years ago, TXL team was a small. It has rapidly grown, and now it has expanding in different countries with 10 distributors worldwide. TXL has completed more than 20 study cases and published in 13 official articles in the International Medical Journal. It has completed two human clinical trial researches. The U.S. National Cancer Institute (NCI), the world’s largest cancer research center formally authorized a Thesaurus Code: C88275 for TXL, which is the very first Chinese herbal medicine being included in the Thesaurus of NCI.

TXL uses the herbs harvested from Changbai Mountain in Jilin Province, China and it has been verified by medicinal studies. This is a compound Chinese herbal medicine developed based on the Chinese medicinal science. TXL is produced under the most advanced biotechnological processes of extraction, and the production undergoes stringent GMP standards and requirements. It contains no chemical substance and toxicity. It is a supplement to help cancer patients to reduce the risk of cancer recurrence.

 

 

Twenty years ago, TXL team was a small. It has rapidly grown, and now it has expanding in different countries with 10 distributors worldwide. TXL has completed more than 20 study cases and published in 13 official articles in the International Medical Journal. It has completed two human clinical trial researches. The U.S. National Cancer Institute (NCI), the world’s largest cancer research center formally authorized a Thesaurus Code: C88275 for TXL, which is the very first Chinese herbal medicine being included in the Thesaurus of NCI.